EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cross‐protection of allergen immunotherapy‐induced antibodies to related allergens requires a high degree of structural identity

Hilal Demir, Christian Radauer iD, Maria R Strobl, Stephan Scheurer, Tamar Kinaciyan, Barbara Bohle iD

Allergy · 2025

DOI: 10.1111/all.16323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2025. Verfasst von Hilal Demir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Aus…. Hauptthemen laut MEDLINE: Allergens, Antigens, Plant, Plant Proteins, Desensitization, Immunologic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Austrian Science Fund, Danube Allergy Research Cluster.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In contrast to sublingual immunotherapy (SLIT) with recombinant Mal d 1 (rMal d 1‐SLIT), SLIT with rBet v 1 (rBet v 1‐SLIT) induced Mal d 1‐cross‐reactive antibodies without IgE‐blocking activity. To elucidate whether the development of cross‐protective IgG responses depends on the degree of molecular identity of allergens we compared the cross‐reactivity, cross‐blocking activity, and affinity of SLIT‐induced antibodies with allergens of varying amino acid sequence identities to Bet v 1 and Mal d 1, namely Cor a 1.04 (hazelnut), Pru av 1 (cherry), and Dau c 1 (carrot).

Methods

Allergen‐specific antibodies were quantified by ELISA. IgE blocking was analyzed by inhibition of allergen‐induced basophil activation and IgE‐facilitated allergen‐presentation to T cells. The affinity of SLIT‐induced antibodies was studied by acidic dissociation ELISA and competition ELISA. Identical surface areas on allergens were predicted using an in‐house designed script based on structural alignments. Results rBet v 1‐SLIT‐induced IgG antibodies cross‐reacted with all allergens except Dau c 1. rMal d 1‐SLIT‐induced antibodies predominantly cross‐reacted with Pru av 1 and displayed significantly higher IgE blocking to Pru av 1 than rBet v 1‐SLIT‐induced antibodies. rMal d 1‐SLIT‐induced IgG1 showed higher affinity to Mal d 1 and Pru av 1. Surface analysis revealed 84% identical area on Mal d 1 and Pru av 1. Furthermore, we identified two surface areas potentially containing epitopes present on these allergens and absent on Bet v 1.

Conclusion

In summary, our findings suggest that a relatively high threshold of similarity is required to establish effective cross‐blocking antibodies to related allergens. Apparently, the structural identity between Bet v 1 and Mal d 1 is below this threshold. Therefore, this study may explain why immunotherapy with birch pollen allergen often fails to reduce birch pollen‐related apple allergy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensAntigens, PlantPlant ProteinsDesensitization, ImmunologicCross ReactionsHumansImmunoglobulin EImmunoglobulin GSublingual ImmunotherapyAmino Acid Sequence

Stichwörter der Autor:innen

allergens and epitopesallergy treatmentbasic immunologybasic mechanismsfood allergyimmune tolerance

Substanzen

AllergensImmunoglobulin EAntigens, PlantPlant ProteinsImmunoglobulin GMALD1 protein, Malus domestica

Autor:innen und Institutionen

  • Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Molecular Allergology, Paul-Ehrlich-Institute, Langen, Germany.
  • Department of Dermatology, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Christian Radauer, Barbara Bohle

Förderung

  • Austrian Science Fund
  • Danube Allergy Research Cluster

Zitieren

APA

Demir, H., Radauer, C., Strobl, M. R., Scheurer, S., Kinaciyan, T., & Bohle, B. (2025). Cross‐protection of allergen immunotherapy‐induced antibodies to related allergens requires a high degree of structural identity. Allergy. https://doi.org/10.1111/all.16323

Vancouver

Demir H, Radauer C, Strobl MR, Scheurer S, Kinaciyan T, Bohle B. Cross‐protection of allergen immunotherapy‐induced antibodies to related allergens requires a high degree of structural identity. Allergy. 2025. doi:10.1111/all.16323

BibTeX
@article{Demir2025,
  author = {Demir, Hilal and Radauer, Christian and Strobl, Maria R and Scheurer, Stephan and Kinaciyan, Tamar and Bohle, Barbara},
  title = {Cross‐protection of allergen immunotherapy‐induced antibodies to related allergens requires a high degree of structural identity},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16323}
}
Kostenlos starten →